Find a Research Expert

Experts
 Menu

Glen A Doherty

Institution

University College Dublin

Contact

Subjects

Medicine & Nursing

Biochemistry

Details
Publications 57
As first author 4
As last author 13
Unique topics 433
Collaborations 94
Sources 13
Are you Glen A Doherty? Click here to provide feedback on your profile.
All
2019
2018
2017
2016
2015
2014
2013
2012
2011
Earlier
All
2019
2018
2017
2016
2015
2014
2013
2012
2011
Earlier

2019

Hypoxia-inducible factor hydroxylase inhibition enhances the protective effects of cyclosporine in colitis.
2018

KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment.
2017

CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis.
2017

European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease.
2017

Increased non‐melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single‐centre cohort study
2017

Patient Education in Inflammatory Bowel Disease: A Patient-Centred, Mixed Methodology Study.
2017

Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn's Disease Treated Until 33 Weeks of Gestation.
2016

Covered self-expanding metal stents for the management of common bile duct stones.
2016

Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.
2016

Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.
2016

Hypoxia-dependent regulation of inflammatory pathways in immune cells
2016

Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.
2016

Letter: Vedolizumab in Pregnancy.
2016

Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis.
2016

Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner.
2015

A randomized controlled trial of an internet-delivered treatment: Its potential as a low-intensity community intervention for adults with symptoms of depression.
2015

Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential.
2015

Body image dissatisfaction: clinical features, and psychosocial disability in inflammatory bowel disease.
2015

DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease Pathogenesis.
2015

Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4(+) T Cells within Colorectal Tumors despite the Presence of Elevated CD39(+) T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1.
2015

Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.
2015

Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.
2015

Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers.
2015

The Stressometer: A Simple, Valid, and Responsive Measure of Psychological Stress in Inflammatory Bowel Disease Patients.
2014

An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis.
2014

Awareness of adverse effects of azathioprine in patients with inflammatory bowel disease--more to be done?
2014

Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: a case report.
2014

Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population.
2014

Mortality in inflammatory bowel disease patients under 65 years of age.
2014

Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive.
2013

A comparative study of short- and medium-term outcomes comparing emergent surgery and stenting as a bridge to surgery in patients with acute malignant colonic obstruction.
2013

A survey of current practices used to maintain surgically induced remission following intestinal resection for Crohn's disease.
2013

Depth-Dependent Differences in Community Structure of the Human Colonic Microbiota in Health
2013

Hydroxylases as therapeutic targets in inflammatory bowel disease.
2013

Keeping the Bowel Regular: The Emerging Role of Treg as a Therapeutic Target in Inflammatory Bowel Disease.
2013

Management of complex colonic polyps in the English Bowel Cancer Screening Programme (Br j surg 2013; 100: 1633-1639).
2013

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
2013

The Body Image Scale: A Simple and Valid Tool for Assessing Body Image Dissatisfaction in Inflammatory Bowel Disease.
2013

The influence of CTGF single-nucleotide polymorphisms on outcomes in Crohn's disease.
2012

Determinants of short- and long-term survival from colorectal cancer in very elderly patients.
2012

Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients.
2012

Prolonged avoidance of repeat surgery with endoscopic balloon dilatation of anastomotic strictures in Crohn's disease.
2012

The Short Health Scale: A valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients.
2011

Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.
2011

Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy.
2009

Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.
2009

Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.
2009

Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer.
2008

Expression of COX-2 and prognostic outcome in uveal melanoma.
2008

Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2.
2008

Microsomal prostaglandin E2 synthase 1 expression in basic calcium phosphate crystal-stimulated fibroblasts: role of prostaglandin E2 and the EP4 receptor.
2006

Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin.
1999

A new monoclonal antibody that specifically recognises the MDR-3-encoded gene product.
1997

A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.
1997

The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
1995

Multiple drug resistance in variants of a human lung cell line exposed to adriamycin and VP-16.
1995

Separation of growth-stimulating activity of BSA fraction V from the bulk of albumin using Heparin Sepharose Chromatography.

These arethe13 unique sources for Glen A Doherty's 57 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin City University 6
Ireland -> Dublin City University -> PubMed 6
Ireland -> Maynooth University 2
Ireland -> Royal College of Surgeons in Ireland 4
Ireland -> Royal College of Surgeons in Ireland -> PubMed 3
Ireland -> Teagasc 1
Ireland -> Teagasc -> PubMed 1
Ireland -> Trinity College Dublin 5
Ireland -> Trinity College Dublin -> PubMed 3
Ireland -> University College Cork 1
Ireland -> University College Dublin 40
Ireland -> University College Dublin -> PubMed 39
Ireland -> University of Limerick 1

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.